#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13046	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2505	641.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1910	1910	T	843	T,C,A,G	838,2,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13046	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2505	641.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1644	1644	C	770	C	770	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13046	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2505	641.1	0	HET	.	.	.	A1208G	.	1208	1208	A	1668	1668	A	761	A,G	401,360	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22148	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4077	677.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1943	1943	A	899	A,G,T	897,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22148	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4077	677.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2577	2577	C	767	C,T,A	762,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22148	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4077	677.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2651	2651	A	758	A	757	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22148	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4077	677.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3203	3203	C	760	C,G,T,A	757,1,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	71142	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	2127	4174.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1876	folP	855	855	100.0	folP.l15.c4.ctg.1	2057	113.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1293	1295	AGC	181;182;182	A;G;C	181;182;182	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4476	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4084	136.9	1	SNP	p	S91F	0	.	.	271	273	TCC	906	908	TCC	161;161;160	T;C;C	161;161;160	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4476	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4084	136.9	1	SNP	p	D95G	0	.	.	283	285	GAC	918	920	GAC	176;179;180	G,C;A;C	175,1;179;180	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4476	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4084	136.9	1	SNP	p	D95N	0	.	.	283	285	GAC	918	920	GAC	176;179;180	G,C;A;C	175,1;179;180	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1632	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1803	112.8	0	.	p	.	0	A39T	NONSYN	115	117	GCC	747	749	ACC	140;141;141	A;C,A;C	140;140,1;141	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1632	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1803	112.8	0	.	p	.	0	L47P	NONSYN	139	141	CTC	771	773	CCC	149;147;147	C;C,T;C	149;146,1;147	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1632	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1803	112.8	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	945	947	CAC	222;223;226	C;A;C	222;223;226	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1632	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1803	112.8	1	SNP	p	G45D	0	.	.	133	135	GGC	765	767	GGC	148;150;152	G;G;C	148;150;152	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1030	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1589	81.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4344	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3616	150.0	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1786	1788	ATC	222;217;219	A;T,G;C,T	222;216,1;217,2	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4344	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3616	150.0	1	SNP	p	D86N	0	.	.	256	258	GAC	892	894	GAC	196;196;194	G;A;C	196;196;194	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4344	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3616	150.0	1	SNP	p	S87R	0	.	.	259	261	AGT	895	897	AGT	191;192;194	A;G;T	191;192;194	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4344	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3616	150.0	1	SNP	p	S87I	0	.	.	259	261	AGT	895	897	AGT	191;192;194	A;G;T	191;192;194	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4344	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3616	150.0	1	SNP	p	S87W	0	.	.	259	261	AGT	895	897	AGT	191;192;194	A;G;T	191;192;194	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4344	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3616	150.0	1	SNP	p	S88P	0	.	.	262	264	TCC	898	900	TCC	197;198;200	T;C,G;C	197;197,1;200	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3804	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3192	148.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1819	1821	GGC	208;209;209	G,T;G;C	207,1;209;209	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3618	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2952	153.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1519	1521	GCA	231;231;230	G;C;A	231;231;230	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3618	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2952	153.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1522	1524	ATC	231;228;230	A;T;C	231;228;230	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3618	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2952	153.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1534	1536	GTG	232;232;230	G;T;G	232;232;230	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3618	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2952	153.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1534	1536	GTG	232;232;230	G;T;G	232;232;230	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3618	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2952	153.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2038	2040	ACC	197;196;195	A;C;C,T	197;196;194,1	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3618	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2952	153.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2092	2094	GCG	185;183;183	G;C;G	185;183;183	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3618	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2952	153.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2092	2094	GCG	185;183;183	G;C;G	185;183;183	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3618	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2952	153.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2215	2217	GGC	190;190;190	G;G;C	190;190;190	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3618	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2952	153.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2224	2226	GGC	187;187;188	G;G,T;C,G	187;186,1;187,1	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3618	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2952	153.0	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2242	2244	TCG	191;188;189	T,G;C;G	189,2;188;189	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4966	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3540	174.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1860	1862	CCG	200;201;203	C;C,T,G,A;G	200;198,1,1,1;203	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2138	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2372	112.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	842	842	C	165	C	165	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	603	605	AAT	13;13;13	A;A;T	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	606	608	AAT	13;13;13	A;A;T	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	630	632	GCA	13;13;13	G;C;A	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	653	655	GTA	13;13;13	G;T;A	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	S236N	NONSYN	706	708	AGC	659	661	AAC	12;11;11	A;A;C	12;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	.	MULTIPLE	709	711	AAC	663	667	TGGCG	11;11;11;11;11	T;G;G;C;G	11;11;11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	D238A	NONSYN	712	714	GAT	669	671	GCT	11;11;11	G;C;T	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	A251V	NONSYN	751	753	GCG	708	710	GTA	21;23;26	G;T;A	21;23;26	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	S271T	NONSYN	811	813	TCG	768	770	ACT	67;67;67	A;C;T	67;67;67	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	774	776	GAT	67;67;67	G;A;T	67;67;67	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	D276N	NONSYN	826	828	GAT	783	785	AAC	67;67;67	A;A;C	67;67;67	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	266	porB1a	984	292	90.2	porB1a.l15.c30.ctg.1	870	20.4	0	.	p	.	0	N277H	NONSYN	829	831	AAC	786	788	CAC	67;67;67	C;A;C	67;67;67	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	2794	porB1b	1041	1041	100.0	porB1b.l15.c30.ctg.1	1898	182.0	1	SNP	p	G120K	1	.	.	358	360	AAG	820	822	AAG	224;222;224	A;A;G	224;222;224	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	2794	porB1b	1041	1041	100.0	porB1b.l15.c30.ctg.1	1898	182.0	1	SNP	p	A121D	1	.	.	361	363	GAC	823	825	GAC	218;217;217	G;A;C,T	218;217;216,1	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	2794	porB1b	1041	1041	100.0	porB1b.l15.c30.ctg.1	1898	182.0	1	SNP	p	D121N	0	.	.	361	363	GAC	823	825	GAC	218;217;217	G;A;C,T	218;217;216,1	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8912	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5414	205.5	0	.	p	.	0	S539G	NONSYN	1615	1617	AGT	2219	2221	GGT	225;226;224	G,A;G,T;T	224,1;225,1;224	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8912	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5414	205.5	0	.	p	.	0	A1019T	NONSYN	3055	3057	GCC	3659	3661	ACC	252;256;255	A;C,T;C	252;254,2;255	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8912	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5414	205.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2261	2263	CAT	223;223;223	C,A;A;T	221,2;223;223	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1298	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1630	99.5	1	SNP	p	V57M	1	.	.	169	171	ATG	840	842	ATG	228;229;229	A;T,G;G,T	228;228,1;228,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
